Literature DB >> 22280553

The functional right ventricle and tricuspid regurgitation in Ebstein's anomaly.

Sohrab Fratz1, Christine Janello, Dorothea Müller, Manuel Seligmann, Christian Meierhofer, Tibor Schuster, Christian Schreiber, Stefan Martinoff, John Hess, Andreas Kühn, Manfred Vogt, Heiko Stern.   

Abstract

BACKGROUND: The size of the functional right ventricle of patients with Ebstein's anomaly is, according to contemporary opinion, small. However, the in vivo size of the functional right ventricle in patients with Ebstein's anomaly is unknown. Furthermore, it is unknown how the apical displacement and regurgitant fraction of the tricuspid valve in Ebstein's anomaly affects the size of the functional right ventricle. Therefore the primary aim of this study was to determine the volume of the functional right ventricle in patients with Ebstein's anomaly. The secondary aim of this study was to assess correlation of the volume of the functional right ventricle to the apical displacement and regurgitant fraction of the tricuspid valve.
METHODS: Thirty-two consecutive patients with Ebstein's anomaly without previous cardiac surgery or shunts were studied prospectively by cardiovascular magnetic resonance. Functional right ventricle, left ventricle, and atrialized right ventricle volumes and tricuspid valve regurgitation were measured.
RESULTS: Functional right ventricle end diastolic volumes were median 127 ml/m² (range: 76-339 ml/m²) and were median 2.5 (range: 1.3-8.8) times larger than the left ventricle volumes. Furthermore, functional right ventricle volumes correlated in a strong positive fashion with tricuspid valve regurgitation (p<0.001, R(2)=0.65) and modestly with the atrialized right ventricle volumes (p=0.027, R(2)=0.16).
CONCLUSION: Patients with untreated Ebstein's anomaly have large functional right ventricles. The size of the enlarged functional right ventricle seems to depend on the degree of tricuspid valve regurgitation and not on the size of the atrialized right ventricle or the age of the patient.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22280553     DOI: 10.1016/j.ijcard.2011.12.081

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Importance of Non-invasive Right and Left Ventricular Variables on Exercise Capacity in Patients with Tetralogy of Fallot Hemodynamics.

Authors:  Christian Meierhofer; Timon Tavakkoli; Andreas Kühn; Kurt Ulm; Alfred Hager; Jan Müller; Stefan Martinoff; Peter Ewert; Heiko Stern
Journal:  Pediatr Cardiol       Date:  2017-08-03       Impact factor: 1.655

2.  Non-invasive Hemodynamic CMR Parameters Predicting Maximal Exercise Capacity in 54 Patients with Ebstein's Anomaly.

Authors:  Christian Meierhofer; Andreas Kühn; Jan Müller; Nerejda Shehu; Alfred Hager; Stefan Martinoff; Heiko Stern; Peter Ewert; Manfred Vogt
Journal:  Pediatr Cardiol       Date:  2019-02-06       Impact factor: 1.655

3.  Detection of early signs of right ventricular systolic impairment in unoperated Ebstein's anomaly by cardiac magnetic resonance feature tracking.

Authors:  Francesca Baessato; Claudia Furtmüller; Nerejda Shehu; Irene Ferrari; Bettina Reich; Nicole Nagdyman; Stefan Martinoff; Heiko Stern; Peter Ewert; Christian Meierhofer
Journal:  Cardiovasc Diagn Ther       Date:  2022-06

4.  Major adverse events and atrial tachycardia in Ebstein's anomaly predicted by cardiovascular magnetic resonance.

Authors:  Riikka Rydman; Yumi Shiina; Gerhard-Paul Diller; Koichiro Niwa; Wei Li; Hideki Uemura; Anselm Uebing; Umberto Barbero; Beatriz Bouzas; Sabine Ernst; Tom Wong; Dudley J Pennell; Michael A Gatzoulis; Sonya V Babu-Narayan
Journal:  Heart       Date:  2017-07-06       Impact factor: 5.994

5.  Atrio-ventricular deformation and heart failure in Ebstein's Anomaly - A cardiovascular magnetic resonance study.

Authors:  Michael Steinmetz; Marike Broder; Olga Hösch; Pablo Lamata; Shelby Kutty; Johannes T Kowallick; Wieland Staab; Christian Oliver Ritter; Gerd Hasenfuß; Thomas Paul; Joachim Lotz; Andreas Schuster
Journal:  Int J Cardiol       Date:  2018-02-03       Impact factor: 4.164

6.  Clinical aspects of myocardial fibrosis in adults with Ebstein's anomaly.

Authors:  Aleksandra Ciepłucha; Olga Trojnarska; Anna Kociemba; Magdalena Łanocha; Mikolaj Barczynski; Szymon Rozmiarek; Lucyna Kramer; Malgorzata Pyda
Journal:  Heart Vessels       Date:  2018-02-21       Impact factor: 2.037

7.  Postoperative persistent diastolic dyssynchronous expansion in patients with Ebstein's anomaly.

Authors:  Kyung-Jin Kim; Kyung-Hwan Kim; Woong-Han Kim; Dae-Won Sohn
Journal:  PLoS One       Date:  2019-08-08       Impact factor: 3.240

8.  Guidelines and protocols for cardiovascular magnetic resonance in children and adults with congenital heart disease: SCMR expert consensus group on congenital heart disease.

Authors:  Sohrab Fratz; Taylor Chung; Gerald F Greil; Margaret M Samyn; Andrew M Taylor; Emanuela R Valsangiacomo Buechel; Shi-Joon Yoo; Andrew J Powell
Journal:  J Cardiovasc Magn Reson       Date:  2013-06-13       Impact factor: 5.364

9.  Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.

Authors:  Dan Yang; Xiao Li; Jia-Yu Sun; Wei Cheng; Andreas Greiser; Tian-Jing Zhang; Hong Liu; Ke Wan; Yong Luo; Qi An; Yiu-Cho Chung; Yuchi Han; Yu-Cheng Chen
Journal:  J Cardiovasc Magn Reson       Date:  2018-09-27       Impact factor: 5.364

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.